Archive: 04/12/2017

Storage in dose administration aids doesn't affect warfarin

(HealthDay)—The chemical stability of warfarin sodium tablets is not affected by repackaging into dose administration aids (DAAs), according to a study published online Nov. 16 in the Journal of Pharmacy Practice and Research.

Dec 4, 2017

0

0

Poor agreement for practitioners in defining myofascial pain

(HealthDay)—Health care practitioner groups differ regarding the signs and symptoms that define myofascial pain syndrome (MPS), according to a study published online Nov. 1 in Pain Practice.

Dec 4, 2017

0

0

For teens, vaping today may lead to smoking tomorrow

(HealthDay)— The e-cigarette may not be just a "healthier alternative" to smoking for teens. New research shows that teens who vape may be more apt to use tobacco cigarettes later on.

Dec 4, 2017

1

0

Differences in cancer survival by type of insurance

(HealthDay)—From 1997 to 2014, improvements in cancer survival were mainly limited to patients with private or Medicare insurance, according to a study published online Nov. 30 in JAMA Oncology.

Dec 4, 2017

0

1

Durotomy: A common complication of spinal surgery—and an important factor in some malpractice cases

Incidental durotomy—small tears of the outer membrane of the spinal cord—are a common occurrence in spinal surgery, and may lead to litigation. Most malpractice cases associated with dural tear end in a ruling in favor ...

Dec 4, 2017

Serious risk of mental health crisis in Yemen, say experts

Yemenis face serious mental health risks, but the issue is being neglected, says a new study released today by Columbia University's Mailman School of Public Health and the Sana'a Center for Strategic Studies, Columbia Law ...

Dec 4, 2017

A new role for an old protein in breast cancer

Scientists led by Dr Chris Toseland of the University's School of Biosciences studied a protein called Myosin VI, a molecular motor which acts as a courier to transport other proteins within our cells. Myosin VI is highly ...

Dec 4, 2017

0

0

FDA approves biosimilar ogivri for breast, stomach cancers

(HealthDay)—Ogivri (trastuzumab-dkst) has been approved by the U.S. Food and Drug Administration as the nation's first biosimilar drug to treat certain breast and stomach cancers, the agency said Friday in a news release.

Dec 4, 2017

0

0

MeToo no more?

(HealthDay)—From the hills of Hollywood to the halls of Congress, it's now clear that sexual harassment in the workplace has long been a fact of life for working women.

Dec 4, 2017

0

0

Study finds surrogate decision makers experience psychological distress

Nearly half of the 13 million older adults hospitalized annually in the United States are unable to make their own medical decisions and rely on surrogates, usually close family members, to make decisions for them. However ...

Dec 4, 2017

page 4 from 11

Archive: 04/12/2017

Storage in dose administration aids doesn't affect warfarin

Poor agreement for practitioners in defining myofascial pain

For teens, vaping today may lead to smoking tomorrow

Differences in cancer survival by type of insurance

Durotomy: A common complication of spinal surgery—and an important factor in some malpractice cases

Serious risk of mental health crisis in Yemen, say experts

A new role for an old protein in breast cancer

FDA approves biosimilar ogivri for breast, stomach cancers

MeToo no more?

Study finds surrogate decision makers experience psychological distress

Phys.org

Tech Xplore

Science X